early diagnosis of pneumocystis carinii pneumonia.

NLM AIDSLINE Early diagnosis of Pneumocystis carinii pneumonia. Blanch J; Torner J; Baucells JM; Collado I; Zuniga E; Hospital Sant
December 30, 1992

Int Conf AIDS. 1992 Jul 19-24;8(3):56 (abstract no. PuB 7047). Unique OBJECTIVES: To assess the efficacy of 67Gallium lung scan at the early detection of the Pneumocystis Carinii Pneumonia (PCP). METHODS: 10 patients have to be studied (9 males, 1 female; median age 28, 6IVDU, 2 homosexual men, 2 heterosexual transmission) without respiratory symptomatology, with CD4 less than 500 mm (ranged from 30-450 with a mean of 124) and with a normal chest radiography. All of them underwent a 67Gallium lung scan. RESULTS: 2 patients had a bilateral diffused imaging, for which reason they underwent a bronchoscopy, so it remained apart in the bronchoalveolar lavage pneumocystis carinii. One month ago the first patient showed an episode of cerebral toxoplasmosis with a quantity of CD4 77 and Pa O2 97. The second patient showed a Kaposi's Sarcoma with a quantity of CD4 60 and Pa O2 95. CONCLUSIONS: In accordance with these information, we believe that 67Gallium lung scan would be useful for patients without respiratory symptomatology with a normal chest radiography, for those who have a diagnosis of disease associated with infection because of the HIV and/or those who have the quantity of CD4 less than 200. There is another point to determine, that is the relation cost-benefits of the method 67Gallium lung scan at the early detection of PCP. Adult Female Gallium Radioisotopes/DIAGNOSTIC USE Human Lung/RADIOGRAPHY/RADIONUCLIDE IMAGING Male Pneumonia, Pneumocystis carinii/RADIOGRAPHY/*RADIONUCLIDE IMAGING Time Factors ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 OHIO: Phila Health Department HIV Testing Well-Received CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention UNITED STATES: New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis INDIA: India Faces TB Drug Shortage, Warns International Medical Org ALASKA: After Topping List for Chlamydia Rates, Alaska Seeing Some Improvement Tanzania: Police Abuse, Torture, Impede HIV Services Growing HIV/AIDS awareness in Indonesia's Papua region South Africa: Catastrophe as Eastern Cape drug stock-outs continue Community-led programmes critical to progress on AIDS in Sri Lanka One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs New Single Virus Detection Techniques for Faster Disease Diagnosis STI diagnoses at 450,000 in England NEW YORK: New York Museum Chronicles Early Days of AIDS in the City CHINA: Hepatitis C Screening Project Planned to Boost Early Detection Experimental Gilead drug effective in early-stage leukemia trial Challenge to overcome earlier anti-gay prejudices Uganda: Early HIV Counselling and Testing Is Only Way to an HIV/AIDS-Free Generation Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013 Stop smoking to reduce risk of pneumonia in HIV+AHF Applauds WHO Decision to Initiate HIV Treatment Earlier
Information in this article was accurate in December 30, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.